Stock Events

Stock Events

Spero Therapeutics (SPRO) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.55

-0.45

-0.35

-0.25

Details

Expected EPS

-0.55

Actual EPS

-0.25

Surprise EPS

0.3

Surprise Percent

+54.55%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.25 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.